$5.12
▼ -1.8% Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
PMGC Holdings Signs Orbit2Orbit Term Sheet for Microgravity Muscle Research
PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss
Overview
52-week range
$4.97
$2.7K
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+3.0%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-11.21 | — | — | -286.6% | +4.0% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.46 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-2.90 | — | — | — | +2.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.07 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.08 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.08 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.08 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.13 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.11 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $681,994 | — | $285,948 | — | — | — | $527,478 |
| Cost of revenue | $920,919 | $451,520 | — | $207,918 | — | — | — | $133,577 |
| Gross profit | $385,691 | $230,474 | — | $78,030 | — | — | — | $393,901 |
| Operating income | — | — | — | $-2M | — | — | — | $-625,615 |
| Net income | $-3M | $-5M | — | $-3M | $-562,355 | $-2M | — | $-2M |
| EPS (diluted) | — | — | — | — | — | — | — | $-0.07 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $18M | $14M | $5M | — | — | — | — | — |
| Inventory | $932,508 | $253,558 | $95,098 | $128,469 | — | — | — | $986,421 |
| Total current assets | $21M | $16M | $7M | $10M | $7M | $7M | $6M | $8M |
| Total assets | $37M | $26M | $13M | $15M | $9M | $9M | $9M | $11M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $20M | $13M | $5M | $6M | $326,301 | $760,268 | $2M | $3M |
| Total equity | $17M | $13M | $8M | $8M | $9M | $8M | $7M | $9M |
Implied volatility — last 90 days
No IV snapshots yet for ELAB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.